Olaparib Combined with Anti-PD1 Enhances Immunotherapy of Gastric Cancer Via NF-kappaB/c-Myc/PD-L1 Signaling. Zheng W, Ge Z, Wu Q, Wan H, et al. Dig Dis Sci 2025 Apr 16. doi: 10.1007/s10620-025-09021.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zheng W, Ge Z, Wu Q, Wan H, et al. Olaparib Combined with Anti-PD1 Enhances Immunotherapy of Gastric Cancer Via NF-kappaB/c-Myc/PD-L1 Signaling. Dig Dis Sci 2025 Apr 16. doi: 10.1007/s10620-025-09021.
PMID: 40237904